▶주메뉴 바로가기
▶본문 바로가기
[THE INVESTOR] LG Household & Health Care said on April 24 its affiliate will purchase a Japanese cosmetics firm for 10.5 billion yen (US$97.60 million) to expand its overseas business. Ginza St...
[THE INVESTOR] Cosmecca Korea, a local cosmetics maker, said on April 24 it has bought a US original design manufacturer in a 57.76 billion won (US$53.70 million) deal as it moves to expand its prese...
[THE INVESTOR] A total of 26 multinational drug companies donated a combined 25.9 billion won (US$24 million) in Korea in 2017, industry data showed on April 24. According to the data by the Kor...
[THE INVESTOR] Korean biopharmaceutical firm Celltrion said on April 20 it has won an approval from an Australian regulator for the sale of its biosimilar drug Truxima. The Therapeutic Goods Adm...
[THE INVESTOR] Korea’s Hanmi Pharmaceutical said on April 18 that it presented preclinical data of its three cancer therapy candidates at the annual meeting of the American Association of Cancer Res...
[THE INVESTOR] Korean security software provider AhnLab said on April 17 it has forged a partnership with Seoul National University Bundang Hospital for research on digital health care. Under the m...
[THE INVESTOR] Bayer Korea on April 17 announced the names of three startups who have been selected for its open innovation program in consultation with KOTRA. This is the second round of Grants4Ap...
[THE INVESTOR] South Korean drugmakers are rushing to roll out generic copies of Pfizer’s smoking cessation drug Champix, as the treatment’s substance patent here was recently broken by a local pate...
[THE INVESTOR] Humedix, a subsidiary of Huons Global , said on April 16 that it has obtained sales approval for two types of injection therapies that repair damaged skin and encourage wound healin...
[THE INVESTOR] Chong Kun Dang Pharmaceutical said on April 16 that it has entered into a partnership with the Japanese unit of a US-based drug maker to export its biosimilar candidate referencing Ky...
[THE INVESTOR] Hanmi Pharmaceutical said on April 13 that it is abandoning the development of Olita, its new lung cancer treatment, as a rival drug has already hit the markets. “We found it difficu...
[THE INVESTOR] Korean stem cell therapy firm CHA Biotech said on April 12 it will set up a new subsidiary to spin off its contract drug manufacturing and basic research business to improve its bal...
[THE INVESTOR] SK Chemicals, the chemical and biopharmaceutical arm of SK Group, has picked a name for the vaccine unit it is planning to spin off this year, a company official said on April 12. Th...
[THE INVESTOR] Daewoong Pharmaceutical said on April 11 it has opened a research center in Indonesia to expand its global network. Located in the University of Indonesia, the Bio Technology Resear...
[THE INVESTOR] ToolGen , Korea’s biotech specialized in genome editing, expects its market capitalization to exceed 1 trillion won (US$938 million) if its stock transfers to the bigger KOSDAQ marke...
GM must stay in Korea for at least 10 years: KDB
Focus on root of all problems: Samsung’s Lee Jae-yong
LG set to acquire automotive light maker ZKW for W1.6tr
Mexican food chain On The Border looking for new owner
GM Korea union losing ground following due diligence
Past comes back to haunt Korean Air’s Cho family
I’m firing my kids: Korean Air’s Cho Yang-ho
Police raid Korean Air
April 24, 2018
